| For: | Zhang HY, Xiao HL, Wang GX, Lu ZQ, Xie MR, Li CS. Predictive value of presepsin and acylcarnitines for severity and biliary drainage in acute cholangitis. World J Gastroenterol 2023; 29(16): 2502-2514 [PMID: 37179587 DOI: 10.3748/wjg.v29.i16.2502] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i16/2502.htm |
| Number | Citing Articles |
| 1 |
Anna G. Kaal, Margot Nieberg, Koen Stegmeijer, Ewout W. Steyerberg, Cees van Nieuwkoop. The diagnostic accuracy of procalcitonin for community-acquired bacteraemia: an updated systematic review and meta-analysis. Clinical Microbiology and Infection 2026; doi: 10.1016/j.cmi.2025.12.029
|
| 2 |
Hongli Xiao, Hanyu Zhang, Guoxing Wang, Yan Wang, Zhimin Tan, Xuelian Sun, Jie Zhou, Meili Duan, Deyuan Zhi, Chenchen Hang, Guoqiang Zhang, Yan Li, Caijun Wu, Haiyan Zhang, Miaorong Xie, Chunsheng Li. COMPARISON AMONG PRESEPSIN, PROCALCITONIN, AND C-REACTIVE PROTEIN IN PREDICTING BLOOD CULTURE POSITIVITY AND PATHOGEN IN SEPSIS PATIENTS. Shock 2024; 61(3): 387 doi: 10.1097/SHK.0000000000002243
|
| 3 |
Yanzhang Du, Wennie A. Wijaya, Wei Hui Liu. Advancements in metabolomics research in benign gallbladder diseases: A review. Medicine 2024; 103(21): e38126 doi: 10.1097/MD.0000000000038126
|
| 4 |
Mei Zhao, Pengjiao Wang, Xiaodong Sun, Dan Yang, Shuo Zhang, Xiaoxia Meng, Min Zhang, Xiuli Gao. Detrimental Impacts of Pharmaceutical Excipient PEG400 on Gut Microbiota and Metabolome in Healthy Mice. Molecules 2023; 28(22): 7562 doi: 10.3390/molecules28227562
|
| 5 |
Min Liu, Rui Shao, Bo Liu, Ziren Tang. Narrative Review: Research Progress and Future Directions of Presepsin in Neurological Prognostication of Adult Post-Return of Spontaneous Circulation (Post-ROSC) Cardiac Arrest Survivors. Journal of Inflammation Research 2026; : 1 doi: 10.2147/JIR.S571744
|
| 6 |
Lili Tang, Weiwei Wan, Jie Zhang, Hongtao Zhang, Yuhao Wang, Xiaoyue Li. ACUTE KIDNEY INJURY FOLLOWING ACUTE CHOLANGITIS: A RISK MULTIPLIER FOR ADVERSE OUTCOMES AND HEALTHCARE UTILIZATION. Shock 2025; 63(2): 226 doi: 10.1097/SHK.0000000000002462
|
| 7 |
Yedu Wen, Changjiang Yang, Yingjiang Ye, Zhanlong Shen, Caihong Wang. Unlocking the therapeutic potential of HDAC inhibitors in colorectal cancer: Mechanisms, efficacy, and future perspectives. Critical Reviews in Oncology/Hematology 2025; 215: 104920 doi: 10.1016/j.critrevonc.2025.104920
|
